Tuberous Sclerosis Complex Associated Neuropsychiatric Disease

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2026-04-27
Clinical Trial Update: A Study to Investigate Behavioral and Other Co-Occurring Outcomes With Epidiolex as Add-On Therapy in Participants Aged 1 to 65 Years of Age With Tuberous Sclerosis Complex [Phase 4]
Phase 4 trial investigating behavioral and neuropsychiatric outcomes with Epidiolex add-on therapy in tuberous sclerosis complex-associated …
CLINICAL_TRIALS research · 2026-03-12
Clinical Trial Update: A Study to Investigate Behavioral and Other Co-Occurring Outcomes With Epidiolex as Add-On Therapy in Participants Aged 1 to 65 Years of Age With Tuberous Sclerosis Complex [Phase 4]
Phase 4 study evaluating Epidiolex as add-on therapy for tuberous sclerosis complex–associated neuropsychiatric disease in ages 1 to 65, cur…